MX3 Diagnostics Welcomes Professor Mark Hargreaves with New Saliva-Based Ketone Test Launch

MX3 Diagnostics Appoints a New Leader and Unveils a Revolutionary Product

On August 21, 2025, MX3 Diagnostics, a pioneer in health and performance technology, made headlines with the announcement of two major initiatives aimed at enhancing athletic performance and health management. The firm appointed Emeritus Professor Mark Hargreaves as the Chair of its Sports Advisory Board and simultaneously launched the world's first saliva-based ketone test strip.

Professor Hargreaves is a notable figure in the field of exercise physiology, accumulating over 35 years of academic experience. He has had the privilege of working with Olympic gold medalists and has dedicated 15 years to the Board of the Victorian Institute of Sport. His rich background in both research and education positions him as an ideal leader to help guide MX3’s innovations and strategic direction.

Michael Luther, the CEO of MX3 Diagnostics, expressed excitement about this new chapter in the company’s journey. "Having Mark on board comes at a crucial moment for MX3 as we seek to expand our impact in the health and athletic sectors. His experience is invaluable as we innovate and deliver groundbreaking tools for athletes, teams, and healthcare professionals globally."

Alongside Hargreaves' appointment, MX3 launched the saliva-based ketone test strip, a pioneering product that underwent rigorous validation through a partnership with Shenzhen Hospital and Monash University. This innovative test has proven to have accuracy comparable to traditional blood-based measures. An intriguing finding from the research indicated its potential utility in managing seizures in children diagnosed with epilepsy.

Professor Hargreaves shared his enthusiasm over this technological advancement: "This ketone test strip is a game-changer. It augments our existing offerings, including the MX3 lactate test strip and the sweat sodium kit. Such advancements hold great potential for enhancing athlete monitoring and training optimization, crucial for both performance and health."

MX3 Diagnostics is redefining personalized health and performance solutions with these exciting developments. Their combination of industry-leading technological innovations and elite leadership aims to set a new benchmark, allowing not only professional athletes but also health-conscious individuals to achieve their best.

About MX3 Diagnostics

Founded in 2017 and headquartered in Austin, Texas, and Melbourne, Australia, MX3 Diagnostics specializes in portable saliva-based hydration testing systems tailored for the sports industry, military, and workplace safety. Their clinically validated biomarker tests are currently utilized by numerous elite sports teams, Fortune 1000 companies, government bodies, and healthcare settings worldwide. To date, MX3 products have facilitated over 7 million tests, helping to optimize health and safety for users.

MX3's commitment to innovation and quality assures athletes and health professionals that they are receiving cutting-edge tools designed to maximize performance and personal health. With the backing of Professor Hargreaves and these new offerings, MX3 Diagnostics is poised to further solidify its position as a leader in health technology.